Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism - PubMed (original) (raw)
Comparative Study
. 1995 Jul 14;280(3):301-10.
doi: 10.1016/0014-2999(95)00208-3.
Affiliations
- PMID: 8566098
- DOI: 10.1016/0014-2999(95)00208-3
Comparative Study
Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism
R R Matsumoto et al. Eur J Pharmacol. 1995.
Abstract
The novel sigma receptor ligands, N(-)[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine (BD1047) and 1(-)[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine (BD1063), were characterized in rats using binding assays and behavioral studies. In radioligand binding studies, the novel ligands showed marked selectivity for sigma binding sites, generally having a 100-fold or better affinity for sigma sites compared to nine other tested receptors (opiate, phencyclidine, muscarinic, dopamine, alpha 1-, alpha 2-, beta-adrenoceptor, 5-HT1, 5-HT2); the only exception was the affinity of BD1047 for beta-adrenoceptors. Competition assays further revealed that the drugs interacted with both sigma 1 and sigma 2 binding sites. Although both drugs had preferential affinities for sigma 1 sites, BD1047 exhibited a higher affinity for sigma 2 sites than BD1063. In behavioral studies, BD1047 and BD1063 had no effects on their own when unilaterally microinjected into the red nucleus of rats, but both compounds attenuated the dystonia produced by the high affinity sigma ligands, di-o-tolylguanidine (DTG) and haloperidol. BD1047 and BD1063 dose-dependently attenuated the dystonia produced by DTG, suggesting a receptor-mediated mechanism, and the dose curve for DTG was shifted to the right in the presence of the novel ligands. BD1047 and BD1063 appear to act as antagonists at sigma sites and may represent promising new tools for probing other functional effects associated with sigma binding sites.
Similar articles
- Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.
Matsumoto RR, Bowen WD, de Costa BR, Houk JC. Matsumoto RR, et al. Brain Res Bull. 1999 Mar 15;48(5):497-508. doi: 10.1016/s0361-9230(99)00029-5. Brain Res Bull. 1999. PMID: 10372510 - Subchronic administration of N-[2-(3,4-dichlorophenyl) ethyl]-N-methyl-2-(dimethylamino) ethylamine (BD1047) alters sigma 1 receptor binding.
Zambon AC, De Costa BR, Kanthasamy AG, Nguyen BQ, Matsumoto RR. Zambon AC, et al. Eur J Pharmacol. 1997 Apr 11;324(1):39-47. doi: 10.1016/s0014-2999(97)00053-8. Eur J Pharmacol. 1997. PMID: 9137911 - Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity.
McCracken KA, Bowen WD, de Costa BR, Matsumoto RR. McCracken KA, et al. Eur J Pharmacol. 1999 Apr 16;370(3):225-32. doi: 10.1016/s0014-2999(99)00113-2. Eur J Pharmacol. 1999. PMID: 10334496 - 1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (sigma1) and sigma-2 (sigma2) receptor ligands: a review.
Berardi F, Abate C, Ferorelli S, Colabufo NA, Perrone R. Berardi F, et al. Cent Nerv Syst Agents Med Chem. 2009 Sep;9(3):205-19. doi: 10.2174/1871524910909030205. Cent Nerv Syst Agents Med Chem. 2009. PMID: 20021355 Review. - Pharmacology of sigma (σ) receptor ligands from a behavioral perspective.
Skuza G. Skuza G. Curr Pharm Des. 2012;18(7):863-74. doi: 10.2174/138161212799436458. Curr Pharm Des. 2012. PMID: 22288408 Review.
Cited by
- Development of benzophenone-alkyne bifunctional sigma receptor ligands.
Guo LW, Hajipour AR, Karaoglu K, Mavlyutov TA, Ruoho AE. Guo LW, et al. Chembiochem. 2012 Oct 15;13(15):2277-89. doi: 10.1002/cbic.201200427. Epub 2012 Sep 23. Chembiochem. 2012. PMID: 23001760 Free PMC article. - Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine.
Barr JL, Zhao P, Brailoiu GC, Brailoiu E. Barr JL, et al. Int J Mol Sci. 2021 May 13;22(10):5160. doi: 10.3390/ijms22105160. Int J Mol Sci. 2021. PMID: 34068146 Free PMC article. - Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.
Kaushal N, Robson MJ, Vinnakota H, Narayanan S, Avery BA, McCurdy CR, Matsumoto RR. Kaushal N, et al. AAPS J. 2011 Sep;13(3):336-46. doi: 10.1208/s12248-011-9274-9. Epub 2011 Apr 15. AAPS J. 2011. PMID: 21494909 Free PMC article. - Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking.
Knowles LG, Armanious AJ, Peng Y, Welsh WJ, James MH. Knowles LG, et al. Addict Neurosci. 2023 Dec;8:100126. doi: 10.1016/j.addicn.2023.100126. Epub 2023 Aug 27. Addict Neurosci. 2023. PMID: 37753198 Free PMC article. - M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.
Ray A, Canal CE, Ehlen JC, Rice KC, Murnane KS. Ray A, et al. Neurotoxicology. 2019 Sep;74:91-99. doi: 10.1016/j.neuro.2019.05.011. Epub 2019 Jun 1. Neurotoxicology. 2019. PMID: 31163210 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases